Prospera Financial Services’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,191
Closed -$4.19M 1460
2025
Q4
$4.19M Buy
+6,191
New +$4.22M 0.07% 282
2024
Q3
Sell
-604
Closed -$294K 1155
2024
Q2
$294K Sell
604
-107
-15% -$53.7K 0.01% 928
2024
Q1
$384K Buy
711
+347
+95% +$190K 0.01% 801
2023
Q4
$202K Buy
+364
New +$171K 0.01% 1004
2023
Q2
Sell
-5,739
Closed -$2.87M 1044
2023
Q1
$2.87M Buy
+5,739
New +$2.75M 0.12% 212
2022
Q2
Sell
-328
Closed -$179K 2084
2022
Q1
$179K Sell
328
-2,072
-86% -$1.09M 0.01% 915
2021
Q4
$1.58M Sell
2,400
-392
-14% -$246K 0.07% 313
2021
Q3
$1.74M Buy
+2,792
New +$1.88M 0.09% 264
2020
Q4
Sell
-278
Closed -$109K 1082
2020
Q3
$109K Buy
+278
New +$103K 0.04% 383

Other funds holding IDXX

Prospera Financial Services's IDXX Position: Q1 2026 in Review

Prospera Financial Services sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 6,191 shares — an estimated $4.19M sold.

Prospera Financial Services first reported a position in IDXX in Q3 2020 and held it in 9 quarters. The position peaked at $4.19M in Q4 2025. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Prospera Financial Services reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Prospera Financial Services sold 6,191 Idexx Laboratories shares in Q1 2026, an estimated $4.19M.
  • Prospera Financial Services first reported a position in Idexx Laboratories in Q3 2020 and held it in 9 quarters.
  • Prospera Financial Services's Idexx Laboratories position peaked at $4.19M in Q4 2025.
  • 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Prospera Financial Services's 13F filing for Q1 2026, filed 14 Apr 2026.